What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Find out Where To Position Dividend Aristocrats Etf In Portfolio to optimize diversification, risk, and income potential within a blended strategy.
18,597 articlesA MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Dorman's 2025 earnings narrative hinges on aftermarket demand, margins, and strategic bets. This guide breaks down wh...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
When doximity stock plunged today, the market focused on earnings quality and future profitability. This article brea...
A sharp 60% drop in CBIZ shares has investors buzzing about risk and value. This guide breaks down why the stock move...
A regulatory milestone sparked a notable move for Oklo shares, highlighting how news on licensing can lift niche ener...
Intuitive Machines faced a notable stock slide this week as broader space-sector volatility and milestone timing conc...
Meta Platforms stock surged this week as investors cheered hints of in-house AI chips and bigger cloud capacity. We b...
Morgan Stanley labels Microsoft the most under-owned megacap as the stock slides this year. A $50 billion AI investme...
Nvidia delivered a blockbuster quarter, but the stock cooled off the next day. This article unpacks the mystery behin...
CoreWeave surged after its IPO, then pulled back dramatically. This guide explains what happened, what the company do...